COVID-19 clinical course and blood groups: Turkish population-based study

dc.authorid0000-0002-3285-417X
dc.authorid0000-0001-9962-8882
dc.authorid0000-0003-4304-9245
dc.authorid0000-0003-1864-0316
dc.authorid0000-0003-2131-2866
dc.authorscopusid56370690600
dc.authorscopusid24471549000
dc.authorscopusid6602557128
dc.authorscopusid56545735000
dc.authorscopusid57189243089
dc.authorscopusid14022986200
dc.authorscopusid55672209100
dc.authorwosidErkurt, Mehmet Ali/ABI-7232-2020
dc.authorwosidYigenoglu, Tugce/ABF-6595-2021
dc.authorwosidBasturk, Abdulkadir/B-1962-2018
dc.authorwosidBaşcı, Semih/AAB-4823-2021
dc.contributor.authorDal, Mehmet Sinan
dc.contributor.authorAta, Naim
dc.contributor.authorAltuntaş, Fevzi
dc.contributor.authorBaşcı, Semih
dc.contributor.authorYigenoğlu, Tuğçe Nur
dc.contributor.authorKorkmaz, Serdal
dc.contributor.authorBirinci, Şuayip
dc.contributor.authorTurgut, Burhan
dc.date.accessioned2022-05-11T14:40:00Z
dc.date.available2022-05-11T14:40:00Z
dc.date.issued2021
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalı
dc.description.abstractBackground/aim: SARS-CoV-2 enters the cell through the binding of the S glycoprotein on the surface of the virus to the angiotensin-converting enzyme 2 (ACE-2) in the host cells and also SARS-CoV S protein binding to ACE-2 was inhibited by anti-A antibodies. The aim of the study was to investigate the relationship between blood groups and the course of COVID-19 in Turkey. Materials and methods: Laboratory confirmed COVID-19 patients aged 18 and over (n = 39.850) were randomized in age and sex -matched groups according to blood groups Results: Advanced age, male sex and blood group A were found to be related with increased rate of intensive care unit (ICU) admission (OR = 1.089, 95% CI: 1.085-1.093 for age; OR = 1.963, 95% CI: 1.737-2.218 for male sex; OR = 1.216, 95% CI: 1.023-1.446 for blood group A). When blood group O individuals were compared to non-O individuals, no significant difference was observed regarding the rate of hospital and ICU admission, mechanical ventilation (MV) support, length of hospital and ICU stay, and case fatality rate (CFR). The CFR in patients with blood group A, B, O, and AB were 2.6%, 2.2%, 3.1%, and 2.3%, respectively. There were no significant differences between Rh-negative and positive patients regarding the rate of hospital and ICU admission (p = 0.280 and p = 0.741, respectively), also the rate of MV support and CFR was similar (p = 0.933 and p = 0.417). Conclusion: Our study revealed that ABO and Rh blood groups do not have any impact on the rate of hospital admission, hospital and ICU stay, MV support, and CFR.
dc.identifier.doi10.3906/sag-2101-321
dc.identifier.endpage1664
dc.identifier.issn1300-0144
dc.identifier.issn1303-6165
dc.identifier.issue4en_US
dc.identifier.pmid33957720
dc.identifier.scopus2-s2.0-85114601200
dc.identifier.scopusqualityQ3
dc.identifier.startpage1659
dc.identifier.urihttps://doi.org/10.3906/sag-2101-321
dc.identifier.urihttps://hdl.handle.net/20.500.11776/8827
dc.identifier.volume51
dc.identifier.wosWOS:000691544700008
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorTurgut, Burhan
dc.language.isoen
dc.publisherTubitak Scientific & Technical Research Council Turkey
dc.relation.ispartofTurkish Journal of Medical Sciences
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectBlood groups
dc.subjectCOVID-19
dc.subjectSARS-CoV-2
dc.subjectNatural Antibodies
dc.subjectGroup Antigens
dc.subjectAbo
dc.subjectComplement
dc.titleCOVID-19 clinical course and blood groups: Turkish population-based study
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
8827.pdf
Boyut:
96.71 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text